NVDA
NVIDIA Corporation
NVDA's fundamentals are strong and it looks cheap: trading at 21x earnings, about a third of its usual 65x. Analysts expect strong earnings growth.
RIME
Algorhythm Holdings, Inc.
There isn't enough reported data to score RIME yet.
NVDA Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| Strong | |
| Strong |
NVDA's revenue, profitability, cash flow and balance sheet are all currently strong.
RIME Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Weak | |
| Weak | |
| Healthy |
RIME's balance sheet is currently healthy, but its revenue, profitability and cash flow are under pressure.
NVDA PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 12x | $166 | — |
| Current | 21x | $166 | — |
| Cheap | 44x | $345 | +108% |
| Fair | 65x | $511 | +207% |
| Expensive | 93x | $734 | +342% |
Historical ranges are pointers, not guarantees.
NVDA's PE is in its cheap range at 21x. If earnings grow as analysts expect, today's price would be 12x next year's earnings.
RIME PE Valuation
RIME has no meaningful PE right now: it lost money over the past year.
NVDA Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Weakening | |
| Broad | |
| Moderate |
Analysts expect strong earnings and revenue growth for NVDA, but weaker profitability.
RIME Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| -- | |
| Limited | |
| High |
Analysts expect RIME's losses to shrink, with revenue growing.
NVDA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $13.77 | +74% |
| Q3 2026 | $7.91 | +125% |
| Q2 2026 | $6.53 | +111% |
| Q1 2026 | $4.90 | +67% |
| Q4 2025 | $4.03 | +59% |
| Q3 2025 | $3.51 | +65% |
| Q2 2025 | $3.10 | +81% |
| Q1 2025 | $2.94 | +147% |
| Q4 2024 | $2.54 | +234% |
NVDA has the edge over RIME on earnings quality, reporting a profit while its opponent remains loss making.
RIME Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | -$3.14 | +$328.44 |
| Q1 2026 | -$3.13 | +$518.21 |
| Q4 2025 | -$7.27 | +$583.41 |
| Q3 2025 | -$358.73 | +$2.86 |
| Q2 2025 | -$331.58 | +$52.01 |
| Q1 2025 | -$521.34 | -$199.75 |
| Q4 2024 | -$590.68 | -$123.09 |
| Q3 2024 | -$361.59 | +$106.41 |
RIME is still losing money, but far less than before: $3.14 per share over the past year, against $590.68 at its worst in late 2024.
NVDA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $96.2B | +106% |
| Q2 2026 | $81.6B | +85% |
| Q1 2026 | $68.1B | +73% |
| Q4 2025 | $57B | +62% |
| Q3 2025 | $46.7B | +56% |
| Q2 2025 | $44.1B | +69% |
| Q1 2025 | $39.3B | +78% |
| Q4 2024 | $35.1B | +94% |
NVDA has the edge over RIME on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 66% | +5.4 points |
| Q2 2026 | 66% | +17 points |
| Q1 2026 | 65% | +3.9 points |
| Q4 2025 | 63% | +0.8 points |
| Q3 2025 | 61% | -1.2 points |
| Q2 2025 | 49% | -16 points |
| Q1 2025 | 61% | -0.5 points |
| Q4 2024 | 62% | +4.9 points |
NVDA has the edge over RIME on profitability, with a higher operating margin.
RIME Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $3M | +11% |
| Q1 2026 | $2.4M | +20% |
| Q4 2025 | $1.4M | -83% |
| Q3 2025 | $1.7M | -84% |
| Q2 2025 | $2.7M | +11% |
| Q1 2025 | $2M | -18% |
| Q4 2024 | $8M | -25% |
| Q3 2024 | $10.6M | -33% |
RIME's revenue is recovering but still below its 2020 peak: $3M last quarter, up 11% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | -90% | -61 points |
| Q1 2026 | -181% | -40 points |
| Q4 2025 | -296% | -212 points |
| Q3 2025 | -90% | -102 points |
| Q2 2025 | -29% | +223 points |
| Q1 2025 | -141% | -47 points |
| Q4 2024 | -84% | -48 points |
| Q3 2024 | 12% | +11 points |
RIME's operating margin was −90% last quarter, down 61 points from the same quarter a year ago.
NVDA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $21.4B | +59% |
| Q2 2026 | $48.6B | +86% |
| Q1 2026 | $34.9B | +124% |
| Q4 2025 | $22.1B | +32% |
| Q3 2025 | $13.5B | -0.3% |
| Q2 2025 | $26.2B | +75% |
| Q1 2025 | $15.6B | +38% |
| Q3 2024 | $13.5B | +113% |
NVDA has the stronger cash trend. Its trailing FCF is up 290% versus its history, compared with RIME at down 354%.
RIME Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q1 2026 | -$3.9M | -$828K |
| Q4 2025 | -$3M | -$1.5M |
| Q3 2025 | $1.1M | +$2.8M |
| Q4 2024 | -$1.5M | -194% |
| Q3 2024 | -$1.7M | -228% |
| Q4 2023 | $1.6M | +26% |
| Q3 2023 | $1.3M | +168% |
| Q2 2023 | -$2.6M | +$1.6M |
RIME has burned cash in most quarters: −$8M over the past year, against −$5M the year before.
NVDA Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.4% | -106M shares |
| 1 year | -1% | -247M shares |
| 3 years | -2.8% | -705M shares |
| 5 years | -4.1% | -1B shares |
| Available history | -1.8% | -435M shares |
NVDA has the edge over RIME on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $19.7B |
| Q2 2026 | $19.3B |
| Q1 2026 | $3.8B |
| Q4 2025 | $12.5B |
| Q3 2025 | $9.7B |
| Q2 2025 | $14.1B |
| Q1 2025 | $7.8B |
| Q4 2024 | $11B |
NVDA spent $55.3B buying back its own shares over the past year, up 30% from the year before.
RIME Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +53% | +5.3M shares |
| 1 year | +513% | +12.7M shares |
| 3 years | +96818% | +15.1M shares |
| 5 years | +232307% | +15.1M shares |
| Available history | +230925% | +15.1M shares |
RIME has 15M diluted shares, up 513% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2023 | — |
NVDA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.1x | Very low |
| Q2 2026 | -0.0x | Net Cash |
| Q1 2026 | -0.0x | Net Cash |
| Q4 2025 | -0.0x | Net Cash |
| Q3 2025 | -0.0x | Net Cash |
| Q2 2025 | -0.1x | Net Cash |
| Q1 2025 | -0.0x | Very low |
| Q4 2024 | -0.0x | Net Cash |
NVDA's net debt is less than a year of its operating earnings (EBITDA), after holding more cash than debt a year ago.
RIME Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2022 | -0.2x | Net Cash |
| Q2 2022 | 0.6x | Very low |
| Q1 2022 | 0.8x | Very low |
| Q4 2021 | 2.5x | Moderate |
| Q3 2021 | -4.2x | Net Cash |
| Q2 2021 | -0.5x | Net Cash |
| Q1 2021 | 0.1x | Very low |
| Q4 2020 | -0.2x | Net Cash |
RIME has more cash than debt.
NVDA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 33.4 | Neutral |
| Stochastic | 18.1 | Oversold |
NVDA's weekly RSI is 33 (neutral) and its Stochastic is 18 (oversold).
RIME Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 33.9 | Neutral |
| Stochastic | 7.8 | Oversold |
RIME's weekly RSI is 34 (neutral) and its Stochastic is 8 (oversold).
NVDA PE vs Technology Sector
| Metric | NVDA | Sector median | Relative |
|---|---|---|---|
| PE | 21x | 28x | 25% below |
| PE % | 0 | 35 | 35 pts below |
NVDA is trading at 21x earnings, a 25% discount to the Technology sector's median of 28x.
RIME PE vs Technology Sector
| Metric | RIME | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 28x | — |
RIME has no meaningful PE right now: it lost money over the past year.
NVDA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $208.9 | 20% below |
| 20 week MA | $212.0 | 22% below |
| 50 week MA | $199.9 | 17% below |
| 100 week MA | $175.1 | 5.1% below |
| 200 week MA | $123.6 | 34% above |
NVDA has fallen below most of its moving averages, though it's still 34% above its 200-week average.
RIME Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $0.13 | 7.7% above |
| 20 week MA | $0.28 | 50% below |
| 50 week MA | $0.82 | 83% below |
| 100 week MA | $2.45 | 94% below |
| 200 week MA | $124.4 | 100% below |
RIME has bounced recently, but its long-term trend is still down: it's above its 8-week average, but 100% below its 200-week average.
NVDA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $5.92 | $13.0 | +119% |
| 2021 | $13.0 | $29.6 | +128% |
| 2022 | $29.6 | $15.2 | -49% |
| 2023 | $15.2 | $49.5 | +226% |
| 2024 | $49.5 | $137.0 | +177% |
| 2025 | $137.0 | $190.5 | +39% |
| 2026 YTD | $190.5 | $166.2 | -13% |
NVDA has the edge over RIME on returns for 2026, with the stronger performance.
RIME Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $1,441.4 | $1,982.0 | +38% |
| 2021 | $1,982.0 | $1,321.9 | -33% |
| 2022 | $1,321.9 | $998.0 | -25% |
| 2023 | $998.0 | $202.0 | -80% |
| 2024 | $202.0 | $16.8 | -92% |
| 2025 | $16.8 | $1.13 | -93% |
| 2026 YTD | $1.13 | $0.14 | -88% |
RIME has finished five years in a row lower, and it's down 88% so far in 2026.